Anemone taipaiensis
Anemone taipaiensis · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Anemone taipaiensis is a botanical species that has garnered significant scientific interest due to its unique pharmacological properties. Research has specifically identified the presence of bioactive compounds within the plant, most notably Saponin B. This chemical constituent is being closely studied for its potent antitumor activities against various cancer cell lines. Current investigations are focusing on the plant's potential efficacy in addressing the challenging conditions associated with glioblastoma. Consequently, this species represents a promising subject in the ongoing search for novel therapeutic agents in oncology.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Ranunculaceae
- Distribution
- Southern America
- Plant Parts
- Not available
Classification
Common Names
Anemone taipaiensis is a distinct species known by several different names depending on the linguistic context. In traditional Chinese characters, it is commonly referred to as 太白銀蓮花. This same name is also represented in simplified Chinese as 太白银莲花 to accommodate different writing standards. These variations in nomenclature reflect the plant's cultural identity within its native regions. Understanding these common names is essential for anyone studying the botanical heritage of this specific anemone.
Sources: Catalogue of Life (COL)
Taxonomy
Anemone taipaiensis is a remarkable organism belonging to the diverse kingdom Plantae. Within this vast biological realm, the species is classified under the class Equisetopsida. It further occupies a specific niche within the order Ranunculales. As a member of the Ranunculaceae family, it shares structural traits with many other flowering plants. Ultimately, its identity is defined by its placement within the well-known genus Anemone.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Ranunculaceae |
| Genus | Anemone |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Anemone taipaiensis is a specialized plant species primarily found within the Asia-temperate ecological zones. Its geographical presence is most notably concentrated throughout various regions of China. Specifically, the plant maintains a robust distribution across the North-Central parts of the country. Understanding these specific habitat patterns helps botanists track the environmental needs of the species. This localized range highlights the unique biological niche that the plant occupies within its native landscape.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Anemone taipaiensis is a self-supporting herb characterized by its distinct growth form. This plant typically maintains a modest stature, reaching a maximum height of 0.48 m. Depending on its environment, the species can grow as small as 0.14 m. However, many specimens commonly settle at a height of approximately 0.31 m. This variability in size highlights the flexible nature of its physical development.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Anemone taipaiensis has emerged as a significant source of medicinal compounds with promising antitumor potential. Research highlights that Saponin B, a novel compound isolated from this plant, exhibits a strong cytostatic effect against human glioblastoma cells. By blocking the cell cycle at the S phase, this substance effectively suppresses the proliferation of malignant glioma cells. The compound further triggers programmed cell death by activating receptor-mediated apoptotic pathways and altering key protein expressions. Consequently, Saponin B represents a potential candidate for the development of new therapeutic strategies against brain tumors.
Compounds
Anemone taipaiensis serves as the source of Saponin B, a novel cytostatic compound with significant therapeutic potential. Research indicates that this specific substance effectively suppresses the growth and proliferation of human glioblastoma cells. By blocking the cell cycle at the S phase, Saponin B disrupts the survival of these malignant brain tumor cells. The compound further induces apoptosis through the activation of receptor-mediated pathways and the modulation of key proteins like Bax and caspase-3. Consequently, Saponin B represents a promising candidate for the development of new antitumor treatments targeting gliomas.
Conditions
Anemone taipaiensis contains Saponin B, a novel compound that effectively treats U87MG GBM cells by suppressing their proliferation. This medicinal plant serves as a source for treatments targeting glioblastoma through the induction of apoptosis. Specifically, its derivatives act to inhibit glioma cell growth and prevent glioma cell survival. Research indicates that these bioactive compounds exert a strong cytostatic effect on human glioma cells. Consequently, Anemone taipaiensis holds significant potential for developing new therapeutics against various forms of glioma.